Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuya Yoshida

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|January 6, 2016
Alterations of Hepatic Metabolism in Chronic Kidney Disease via D-box-binding Protein Aggravate the Renal DysfunctionKengo Hamamura, Naoya Matsunaga, Eriko Ikeda, et al.
Theranostics|January 2, 2025
Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defenseYuya Yoshida, Tomohito Tanihara, Keika Hamasaki, et al.
International Journal of Molecular Sciences|February 10, 2024
Prostaglandin F2α Affects the Cycle of Clock Gene Expression and Mouse BehaviorYuya Tsurudome, Yuya Yoshida, Kengo Hamamura, et al.
Biochemical and Biophysical Research Communications|March 24, 2024
Circadian rhythms in CYP2A5 expression underlie the time-dependent effect of tegafur on breast cancerYuya Yoshida, Taiki Fukuda, Tomohito Tanihara, et al.
The Journal of Biological Chemistry|June 26, 2025
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancerTomohito Tanihara, Yuya Yoshida, Takashi Ogino, et al.
The Tohoku Journal of Experimental Medicine|February 12, 2025
Outcomes of Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Study Using Real-World DataTomoyuki Iwasaki, Masanobu Takahashi, Kota Ouchi, et al.
Biochemical and Biophysical Research Communications|May 17, 2024
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65Junhao Li, Kengo Hamamura, Yuya Yoshida, et al.
Familial Cancer|February 3, 2026
Attenuated Li-Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case reportYuki Kasahara, Masanobu Takahashi, Yoshifumi Kawamura, et al.
Journal of Medicinal Chemistry|October 13, 2022
Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL ProteaseYuya Hirose, Naoya Shindo, Makiko Mori, et al.
JCO Precision Oncology|April 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling PathwayKen Saijo, Hiroo Imai, Tomoyuki Iwasaki, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|January 6, 2016
Alterations of Hepatic Metabolism in Chronic Kidney Disease via D-box-binding Protein Aggravate the Renal DysfunctionKengo Hamamura, Naoya Matsunaga, Eriko Ikeda, et al.
Theranostics|January 2, 2025
Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defenseYuya Yoshida, Tomohito Tanihara, Keika Hamasaki, et al.
International Journal of Molecular Sciences|February 10, 2024
Prostaglandin F2α Affects the Cycle of Clock Gene Expression and Mouse BehaviorYuya Tsurudome, Yuya Yoshida, Kengo Hamamura, et al.
Biochemical and Biophysical Research Communications|March 24, 2024
Circadian rhythms in CYP2A5 expression underlie the time-dependent effect of tegafur on breast cancerYuya Yoshida, Taiki Fukuda, Tomohito Tanihara, et al.
The Journal of Biological Chemistry|June 26, 2025
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancerTomohito Tanihara, Yuya Yoshida, Takashi Ogino, et al.
The Tohoku Journal of Experimental Medicine|February 12, 2025
Outcomes of Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Study Using Real-World DataTomoyuki Iwasaki, Masanobu Takahashi, Kota Ouchi, et al.
Biochemical and Biophysical Research Communications|May 17, 2024
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65Junhao Li, Kengo Hamamura, Yuya Yoshida, et al.
Familial Cancer|February 3, 2026
Attenuated Li-Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case reportYuki Kasahara, Masanobu Takahashi, Yoshifumi Kawamura, et al.
Journal of Medicinal Chemistry|October 13, 2022
Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL ProteaseYuya Hirose, Naoya Shindo, Makiko Mori, et al.
JCO Precision Oncology|April 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling PathwayKen Saijo, Hiroo Imai, Tomoyuki Iwasaki, et al.
Pageof 12